Cingulate Announces Closing of $7.5 Million Public Offering

Stock Information for Issuer Direct Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Issuer Direct Corporation

Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
Cingulate to Participate in Benzinga All Live Access Event
Cingulate to Attend DCAT Week 2024 in New York City
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
Cingulate Announces Pricing of $7.5 Million Public Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.